The coronavirus variant in Brazil is now the second most common in the United States

PFIZER

WHEN WAS IT APPROVED? December 11, 2020

WHO CAN GET IT? Anyone 16 years of age or older

DOSAGE: 2 doses, administered at a distance of 21 days

HOW IT WORKS? Use messenger RNA to provide some genetic code from the virus to “teach” the body to produce a protein that causes the production of antibodies

HOW EFFICIENT IS IT …

AFTER 2 DOSES: 95% effective in disease prevention; 100% effective in preventing death COVID-19; 87% effective in preventing hospitalization

AFTER THE FIRST DOSE: (not recommended) ~ 46% effective in preventing infection seven to 20 days later; 57% effective against symptomatic diseases; 72% effective in preventing death; 74% effective against hospitalization; 62% effective against severe diseases (based on real-world data from Israel)

AGAINST VARIANTS FROM …

United Kingdom – B117: No significant impact

South Africa – B1351: 10% less efficient; still protective

Brazil – P1: Antibodies 10.4 times weaker; still protective

MODERN

WHEN WAS IT APPROVED? December 18, 2020

WHO CAN GET IT? Anyone 18 years of age or older

DOSAGE: 2 doses, administered at a distance of 28 days

HOW IT WORKS? Use messenger RNA to provide some genetic code from the virus to “teach” the body to produce a protein that causes the production of antibodies

HOW EFFICIENT IS IT …

AFTER 2 DOSES: 94% effective in disease prevention; 100% effective in preventing death COVID-19; 89% effective in preventing hospitalization

AFTER THE FIRST DOSE: (not recommended) ~ 80% effective, based on test data

AGAINST VARIANTS FROM …

Great Britain – B117: No significant impact

South Africa – B1351: 10% less efficient; still protective

Brazil – P1: More data required

JOHNSON & JOHNSON

WHEN WAS IT APPROVED? February 27, 2021

WHO CAN GET IT? Anyone 18 years of age or older

DOSAGE: 1 dose

HOW IT WORKS? Use a harmless, cold, inactivated virus to carry a piece of spike protein in the body to teach it to fight SARS-CoV-2

HOW EFFICIENT IS IT …

After a single dose: 72% worldwide; 86% in the USA

AGAINST VARIANTS FROM …

United Kingdom – B117: No significant impact

South Africa – B1351: 64% efficient

Brazil – P1: 85% efficient

.Source